DJIA 17,387.21 -291.49 -1.65%
NASDAQ 4,681.50 -90.27 -1.89%
S&P 500 2,029.55 -27.54 -1.34%
market minute promo

33.54 -0.01 (-0.03%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NBIX $33.54 -0.03%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.05
Previous Close $33.55
Daily Range $32.80 - $34.31
52-Week Range $12.17 - $34.31
Market Cap $2.5B
P/E Ratio -46.60
Dividend (Yield) $0.00 (0.0%)
Volume 821,175
Average Daily Volume 1,398,278
Current FY EPS -$0.80

Sector

Healthcare

Industry

Drugs

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary Rss Feed

Cancel JPMorgan! Plenty of Pre-Conference Data and Deals to Digest

The week before JPMorgan Healthcare conference brought a plethora of deals and data.

Stocks Hitting 52-Week Highs

Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 4

Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot

Why Neurocrine Biosciences, Inc. Shares Took Off Today

Is this meaningful? Or just another movement?

Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

Mid-Morning Market Update: Markets Jump; Family Dollar Profit Misses Estimates

Benzinga's Volume Movers

6 Serious Biotech and Health Care Movers

Our 3 Best Performing Stocks Of 2014

See More NBIX News...

NBIX's Top Competitors

NBIX $33.54 (-0.03%)
Current stock: NBIX
AMGN $158.42 (-0.82%)
Current stock: AMGN
GILD $105.03 (-1.94%)
Current stock: GILD
BIIB $358.23 (-1.16%)
Current stock: BIIB